Molecular mechanism of regulation of growth factor receptor sorting at endosomes
内体生长因子受体分选调节的分子机制
基本信息
- 批准号:17370045
- 负责人:
- 金额:$ 9.28万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2005
- 资助国家:日本
- 起止时间:2005 至 2006
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Upon binding of growth factors to their cell surface receptors, the growth factor/receptor complexes are internalized and transported to early endosomes. After sorted at early endosomes, the complexes are further transported to lysosome and degraded. Conjugation of ubiquitin to the receptors serves as a sorting signal for transport to lysosomes. In this study, we examined the role of the deubiquitinating enzyme UBPY and ALG2 in regulation of growth factor receptor sorting at endosomes, and the following results were obtained.(1)Overexpression of UBPY reduced the ubiquitination level of EGF receptor (EGFR), and delayed its degradation in EGF-stimulated cells. Overexpression of Hrs caused the accumulation of endogenous UBPY on exaggerated endosomes. A catalytically inactive UBPY mutant clearly localized on endosomes, where it overlapped with EGFR when cells were stimulated with EGF. Depletion of endogenous UBPY by RNA interference resulted in elevated ubiquitination and accelerated degradation of EGF-activated EGFR. These results suggest that UBPY negatively regulates the rate of EGFR degradation by deubiquitinating EGFR on endosomes.(2)At endosomes, ligand-activated receptors are incorporated into luminal vesicles of endosomes that bud inward from its limiting membrane. Endosomes that contain such luminal vesicles are called the multivesicular body (MVB). We examined the role of ALG2 in the formation of the luminal vesicles. Depletion of endogenous ALG2 by RNA interference resulted in the reduction of the level of phospholipid LBPA, which is specifically localized to the membrane of the luminal vesicles. This reduction was also observed by an electron microscopy analysis. These results suggest thatALG2 plays an important role in the formation of the luminal vesicles in MVB.
在生长因子与其细胞表面受体结合后,生长因子/受体复合物被内化并转运至早期内体。在早期的内体中分选后,复合物被进一步运输到溶酶体并降解。泛素与受体的结合作为转运至溶酶体的分选信号。在这项研究中,我们研究了去泛素化酶UBPY和ALG 2在调节内体生长因子受体分选中的作用,并获得了以下结果。(1)UBPY过表达可降低EGF受体(EGFR)的泛素化水平,延缓EGF刺激后EGFR的降解。Hrs的过表达引起内源性UBPY在夸张的内体上的积累。无催化活性的UBPY突变体明显定位于内体,当细胞用EGF刺激时,它与EGFR重叠。通过RNA干扰消除内源性UBPY导致EGF激活的EGFR的泛素化升高和加速降解。这些结果表明,UBPY通过使内体上的EGFR去泛素化来负调节EGFR降解速率。(2)At在核内体中,配体激活的受体被掺入到从其界膜向内出芽的核内体的腔囊泡中。含有这种腔囊泡的内体被称为多泡体(MVB)。我们研究了ALG 2在腔囊泡形成中的作用。通过RNA干扰消耗内源性ALG 2导致磷脂LBPA水平的降低,磷脂LBPA特异性地定位于腔囊泡的膜。通过电子显微镜分析也观察到这种减少。这些结果表明ALG 2在MVB腔囊泡的形成中起重要作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Enhanced JNK activation by NESK without kinase activity upon caspase-mediated cleavage during apoptosis
- DOI:10.1016/j.cellsig.2005.03.004
- 发表时间:2005-11-01
- 期刊:
- 影响因子:4.8
- 作者:Kakinuma, H;Inomata, H;Kitamura, N
- 通讯作者:Kitamura, N
Regulation of EGF receptor downregulation by UBPY-mediated deubiquitination at endosomes
UBPY 介导的内体去泛素化调节 EGF 受体下调
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Moriyama-Kita M;et al.;佐藤 博;E. Shirako;A. Kondo;E. Mizuno;M.Nakamura;E.Mizuno;M.Maemura;A.Yamasaki;M.Nakamura;M.Komada;H.Kakinuma;H.Tanaka;J.Han;E.Mizuno
- 通讯作者:E.Mizuno
A deubiquitinating enzyme UB`Y regulates the level of protein ubiquitination on endosomes
去泛素化酶 UB`Y 调节内体上蛋白质泛素化的水平
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:M.Nakamura;E.Mizuno;A.Yamasaki;M.Nakamura et al.;E.Mizuno et al.;A.Yamasaki et al.;M.Nakamura;E.Mizuno
- 通讯作者:E.Mizuno
Hepatocyte growth factor induces redistribution of p21CIP1 and p27KIP1 through ERK-dependent p16INK4a up-regulation, leading to cell cycle arrest at G1 in HepG2 hepatoma cells
- DOI:10.1074/jbc.m503431200
- 发表时间:2005-09-09
- 期刊:
- 影响因子:4.8
- 作者:Han, JH;Tsukada, Y;Tanaka, T
- 通讯作者:Tanaka, T
The Ca^<2+>-binding protein ALG-2 is recruited to ER exit sites by Sec31A and stabilizes the localization of Sec31A
Ca^2结合蛋白ALG-2被Sec31A募集至ER出口位点并稳定Sec31A的定位
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Moriyama-Kita M;et al.;佐藤 博;E. Shirako;A. Kondo;E. Mizuno;M.Nakamura;E.Mizuno;M.Maemura;A.Yamasaki
- 通讯作者:A.Yamasaki
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KITAMURA Naomi其他文献
KITAMURA Naomi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KITAMURA Naomi', 18)}}的其他基金
Regulation of the endosomal sorting and intracellular signaling ofgrowth factor receptors
生长因子受体内体分选和细胞内信号传导的调节
- 批准号:
19370050 - 财政年份:2007
- 资助金额:
$ 9.28万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular mechanism of endosomal sorting of growth factors and receptors
生长因子和受体内体分选的分子机制
- 批准号:
15370053 - 财政年份:2003
- 资助金额:
$ 9.28万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Characterization of the regulatory mechanism of endocytosis of growth factors and receptors
生长因子和受体内吞调节机制的表征
- 批准号:
13480235 - 财政年份:2001
- 资助金额:
$ 9.28万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Characterization of hepatocyte growth factor activator inhibitors which are being developed for a medicine
正在开发的药物肝细胞生长因子激活剂抑制剂的表征
- 批准号:
13557012 - 财政年份:2001
- 资助金额:
$ 9.28万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Functional characterization of novel regulators of vesicular transport in endocytosis and exocytosis
胞吞作用和胞吐作用中囊泡运输的新型调节剂的功能表征
- 批准号:
11480206 - 财政年份:1999
- 资助金额:
$ 9.28万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
Characterization of factors regulating the activity of hepatocyte growth factor which is being developed for a medicine
正在开发用于药物的肝细胞生长因子活性调节因子的表征
- 批准号:
10557017 - 财政年份:1998
- 资助金额:
$ 9.28万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Characterization of factors regulating the activity of hepatocyte growth factor which is being developed for a medicine
正在开发用于药物的肝细胞生长因子活性调节因子的表征
- 批准号:
09480161 - 财政年份:1997
- 资助金额:
$ 9.28万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Functional characterization of a novel tyrosine phosphorylated protein in signal transduction of hepatocyte growth factor
新型酪氨酸磷酸化蛋白在肝细胞生长因子信号转导中的功能表征
- 批准号:
07458164 - 财政年份:1995
- 资助金额:
$ 9.28万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Structural and functional characterization of a novel serine protease responsible for activation of hepatocyte growth factor
负责肝细胞生长因子激活的新型丝氨酸蛋白酶的结构和功能表征
- 批准号:
05454625 - 财政年份:1993
- 资助金额:
$ 9.28万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
Functional analysis of domain structures of human hepatocyte growth factor
人肝细胞生长因子结构域的功能分析
- 批准号:
02454540 - 财政年份:1990
- 资助金额:
$ 9.28万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
相似国自然基金
清肝泻肺方调节肺巨噬细胞endosome磷脂氧化治疗流感病毒性肺炎的作用研究
- 批准号:
- 批准年份:2021
- 资助金额:56 万元
- 项目类别:面上项目
BNIP-2调控E-cadherin细胞内分选运输的机制研究
- 批准号:32100540
- 批准年份:2021
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
W09D10.1/SMAP在高尔基体至内体的极性胞吐运输中的功能机制研究
- 批准号:91954113
- 批准年份:2019
- 资助金额:82.0 万元
- 项目类别:重大研究计划
KXD1调控血小板α颗粒发生的分子细胞机制
- 批准号:31900496
- 批准年份:2019
- 资助金额:26.0 万元
- 项目类别:青年科学基金项目
Vici综合症蛋白EPG5协同调控内吞运输和自噬通路的机制研究
- 批准号:31871426
- 批准年份:2018
- 资助金额:59.0 万元
- 项目类别:面上项目
TBC1d23调节细胞器互作及突变引起脑桥小脑发育不全的机制研究
- 批准号:91854121
- 批准年份:2018
- 资助金额:89.0 万元
- 项目类别:重大研究计划
Gαs参与调控早期内体分选的机制研究
- 批准号:31701247
- 批准年份:2017
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
植物ESCRT复合物组分蛋白的泛素化修饰及其调控膜蛋白转运和降解的分子机制研究
- 批准号:31701246
- 批准年份:2017
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
Rab7酶和TBC1d5调节Retromer运输的机制研究
- 批准号:31671477
- 批准年份:2016
- 资助金额:25.0 万元
- 项目类别:面上项目
相似海外基金
Development of antibody drug conjugates as pan-filo antivirals
开发作为泛型抗病毒药物的抗体药物偶联物
- 批准号:
10759731 - 财政年份:2023
- 资助金额:
$ 9.28万 - 项目类别:
In-depth molecular studies of dynein transport in the RPE
RPE 中动力蛋白运输的深入分子研究
- 批准号:
10573020 - 财政年份:2023
- 资助金额:
$ 9.28万 - 项目类别:
Application of New Tools for Probing the Roles of Sphingolipids and Cholesterol in Influenza Virus Infection
应用新工具探索鞘脂和胆固醇在流感病毒感染中的作用
- 批准号:
10678459 - 财政年份:2023
- 资助金额:
$ 9.28万 - 项目类别:
Effects of Aging on Neuronal Lysosomal Damage Responses Driven by CMT2B-linked Rab7
衰老对 CMT2B 相关 Rab7 驱动的神经元溶酶体损伤反应的影响
- 批准号:
10678789 - 财政年份:2023
- 资助金额:
$ 9.28万 - 项目类别:
The impact of alcohol-induced ATF6-mediated ER stress and Golgi disorganization on pro-metastatic glycosylation of integrins in prostate cancer
酒精诱导的 ATF6 介导的 ER 应激和高尔基体解体对前列腺癌整合素促转移糖基化的影响
- 批准号:
10826211 - 财政年份:2023
- 资助金额:
$ 9.28万 - 项目类别:
Targeting tumor microenvironment by nanoimmunodrugs for glioma treatment
纳米免疫药物靶向肿瘤微环境治疗神经胶质瘤
- 批准号:
10743942 - 财政年份:2023
- 资助金额:
$ 9.28万 - 项目类别:
Uncovering the role of inppl1a in notochord vacuolation and the development of a straight body axis.
揭示 inppl1a 在脊索空泡化和直体轴发育中的作用。
- 批准号:
10826125 - 财政年份:2023
- 资助金额:
$ 9.28万 - 项目类别:
A novel mitochondria-to-lysosome stress signaling pathway in degenerative disease and aging
退行性疾病和衰老中一种新的线粒体到溶酶体应激信号通路
- 批准号:
10722759 - 财政年份:2023
- 资助金额:
$ 9.28万 - 项目类别:
The functional and adaptive roles of RNA recoding
RNA重编码的功能和适应性作用
- 批准号:
10723394 - 财政年份:2023
- 资助金额:
$ 9.28万 - 项目类别:
Novel Disease-modifying Small Molecules for Treatment of Alzheimer's Disease”
用于治疗阿尔茨海默病的新型疾病修饰小分子 –
- 批准号:
10485602 - 财政年份:2023
- 资助金额:
$ 9.28万 - 项目类别:














{{item.name}}会员




